Febuxostat | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Febuxostat
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Febuxostat

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

85 API Suppliers, 32 USDMF, 12 JDMF, 21 EU WC, 4 KDMF, 23 NDC API, 56 Listed Suppliers, $ API Reference Price

85 API Suppliers
32 USDMF
12 JDMF
21 EU WC
4 KDMF
23 NDC API
56 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

38 Intermediate Suppliers

38 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

155 FDF Dossiers, 34 FDA Orange Book, 54 Europe, 1 Canada, 2 Australia, 64 Listed Dossiers

155 FDF Dossiers
34 FDA Orange Book
54 Europe
1 Canada
2 Australia
64 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 40MG, TABLET;ORAL - 80MG

TABLET;ORAL - 40MG
TABLET;ORAL - 80MG

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 1 DKSH, 3 Faran Shimi Pharmaceutical, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 5 DFE Pharma, 4 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 17 Kerry, 9 Microlex e.U, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 8 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Vasa Pharmachem

1 SPI Pharma
1 DKSH
3 Faran Shimi Pharmaceutical
4 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
5 DFE Pharma
4 Gangwal Chemicals
1 Ideal Cures Pvt Ltd
1 Ingredion Pharma Solutions
17 Kerry
9 Microlex e.U
1 Pharmatrans-Sanaq
3 Pluviaendo
3 Prachin Chemical
8 Roquette
3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
10 Sigachi Industries
3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

37 Fillers, Diluents & Binders, 13 Disintegrants & Superdisintegrants, 12 Direct Compression, 10 Granulation, 10 Lubricants & Glidants, 10 Thickeners and Stabilizers, 7 Co-Processed Excipients, 3 Controlled & Modified Release, 3 Emulsifying Agents, 2 Rheology Modifiers, 2 Chewable & Orodispersible Aids, 2 Coating Systems & Additives, 2 Taste Masking, 1 API Stability Enhancers, 1 Parenteral, 1 Film Formers & Plasticizers

37 Fillers, Diluents & Binders
13 Disintegrants & Superdisintegrants
12 Direct Compression
10 Granulation
10 Lubricants & Glidants
10 Thickeners and Stabilizers
7 Co-Processed Excipients
3 Controlled & Modified Release
3 Emulsifying Agents
2 Rheology Modifiers
2 Chewable & Orodispersible Aids
2 Coating Systems & Additives
2 Taste Masking
1 API Stability Enhancers
1 Parenteral
1 Film Formers & Plasticizers

DIGITAL CONTENT

41 NEWS #PharmaBuzz

41 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 44 Finished Drug Prices, 10 Annual Reports

2 US Medicaid Prescriptions
44 Finished Drug Prices
10 Annual Reports

MARKET PLACE

24 APIs, 3 FDF Dossiers

24 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 US Patents, 4 Health Canada Patents

6 US Patents
4 Health Canada Patents

REF. STANDARDS & IMPURITIES

29 Others

29 Others

$ API Ref.Price (USD/KG) : 365 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 3Smart & Biggar

02 1Takeda Canada Inc.

filter Patent Reset all filters

4 All

01 12073981

02 12301863

03 12474674

04 12566652

filter Product Reset all filters

4 All

01 4Febuxostat

filter Dosage Reset all filters

4 All

01 4Tablet, Immediate Release

filter Exp Date Reset all filters

4 All

01 12011-11-29

02 22019-06-18

03 12023-03-28

Product Main Page

01

Smart & Biggar

Febuxostat

BioAsia

Not Confirmed

Smart & Biggar

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-06-18

Date Granted : 2008-10-21

Brand Name : ULORIC

Patent Number : 2566652

Filing Date : 1999-06-18

Strength per Unit : 80 mg

Dosage Form : Tablet, Immediate Release

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-06-18

Date Granted : 2008-10-21

Portfolio PDF

Product Web Link

Digital Content

02

Takeda Canada Inc.

Febuxostat

BioAsia

Not Confirmed

Takeda Canada Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-11-29

Date Granted : 2002-01-08

Brand Name : ULORIC

Patent Number : 2073981

Filing Date : 1991-11-29

Strength per Unit : 80 mg

Dosage Form : Tablet, Immediate Release

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-11-29

Date Granted : 2002-01-08

Portfolio PDF

Product Web Link

Digital Content

03

Smart & Biggar

Febuxostat

BioAsia

Not Confirmed

Smart & Biggar

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-06-18

Date Granted : 2009-01-27

Brand Name : ULORIC

Patent Number : 2301863

Filing Date : 1999-06-18

Strength per Unit : 80 mg

Dosage Form : Tablet, Immediate Release

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-06-18

Date Granted : 2009-01-27

Portfolio PDF

Product Web Link

Digital Content

04

Smart & Biggar

Febuxostat

BioAsia

Not Confirmed

Smart & Biggar

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-03-28

Date Granted : 2011-04-19

Brand Name : ULORIC

Patent Number : 2474674

Filing Date : 2003-03-28

Strength per Unit : 80 mg

Dosage Form : Tablet, Immediate Release

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-03-28

Date Granted : 2011-04-19

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!